Shaaban, S. G., Chen, H., Singla, N., Tran, A., Hu, C., Ke, S., . . . Deville, C. Prospective phase II study of stereotactic body proton therapy for treatment of primary renal cell carcinoma (SPARE): Clinical trial protocol. BMC.
Chicago Style (17th ed.) CitationShaaban, Sherif G., Hao Chen, Nirmish Singla, Anh Tran, Chen Hu, Suqi Ke, Thomas W. Jarrett, and Curtiland Deville. Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (SPARE): Clinical Trial Protocol. BMC.
MLA (9th ed.) CitationShaaban, Sherif G., et al. Prospective Phase II Study of Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma (SPARE): Clinical Trial Protocol. BMC.
Warning: These citations may not always be 100% accurate.